Terms: = Breast cancer AND MUC16, CA125, CA-125 AND Prognosis
79 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Potential Value of HSP90α in prognosis of Triple-Negative breast cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract] [Full Text] [Related]
3. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
4. Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy.
Yin G; Liu L; Yu T; Yu L; Feng M; Zhou C; Wang X; Teng G; Ma Z; Zhou W; Ye C; Zhang J; Ji C; Zhao L; Zhou P; Guo Y; Meng X; Fu Q; Zhang Q; Li L; Zhou F; Zheng C; Xiang Y; Guo M; Wang Y; Wang F; Huang S; Yu Z
Genome Med; 2024 Jan; 16(1):11. PubMed ID: 38217005
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D; Yang L; Jin Y; Qi H; Liu Y; Ren L
BMC Med Inform Decis Mak; 2023 Nov; 23(1):276. PubMed ID: 38031071
[TBL] [Abstract] [Full Text] [Related]
6. Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.
Chi Y; Su M; Zhou D; Zheng F; Zhang B; Qiang L; Ren G; Song L; Bu B; Fang S; Yu B; Zhou J; Yu J; Li H
Elife; 2023 Nov; 12():. PubMed ID: 37929934
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a muc16 mutation-associated immune prognostic model for lung adenocarcinoma.
Liu H; Xin T; Duan H; Wang Y; Shao C; Zhu Y; Wang J; He J
Aging (Albany NY); 2023 Jun; 15(12):5650-5661. PubMed ID: 37341998
[TBL] [Abstract] [Full Text] [Related]
9. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study.
Gunnarsdottir FB; Bendahl PO; Johansson A; Benfeitas R; Rydén L; Bergenfelz C; Larsson AM
Breast Cancer Res; 2023 Mar; 25(1):29. PubMed ID: 36945037
[TBL] [Abstract] [Full Text] [Related]
10. Correlation of TBK1, AR, and other serum cancer-related biomarkers in breast cancer patients: An observational study.
Liu H; Li H; Zhang J; Meng Q; Ma L
Medicine (Baltimore); 2022 Aug; 101(33):e29996. PubMed ID: 35984205
[TBL] [Abstract] [Full Text] [Related]
11. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, cancer Antigen 153 and cancer Antigen 125 in Metastatic breast cancer.
Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
[TBL] [Abstract] [Full Text] [Related]
13. Bioinformatic Analysis of Immune Significance of RYR2 Mutation in breast cancer.
Xu Z; Xiang L; Wang R; Xiong Y; Zhou H; Gu H; Wang J; Peng L
Biomed Res Int; 2021; 2021():8072796. PubMed ID: 34888385
[TBL] [Abstract] [Full Text] [Related]
14. High GNG13 expression is associated with poor survival in epithelial ovarian cancer and breast cancer.
Liu Y; Gu S; Wu T; Xu Y; Meng Q; Guan Z; Zhang X; Sun X; Shen Y; Fan H; Gu C; Feng J
Neoplasma; 2022 Jan; 69(1):183-192. PubMed ID: 34734529
[TBL] [Abstract] [Full Text] [Related]
15. Carbohydrate antigen 125, carbohydrate antigen 15-3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer.
Tang J; Yan B; Li GF; Li QY; Liu WF; Liang RB; Ge QM; Shao Y
Medicine (Baltimore); 2021 Oct; 100(43):e27693. PubMed ID: 34713867
[TBL] [Abstract] [Full Text] [Related]
16. Lanthanide Nanoprobes for the Multiplex Evaluation of breast cancer Biomarkers.
Chen X; Song H; Li Z; Liu R; Lv Y
Anal Chem; 2021 Oct; 93(40):13719-13726. PubMed ID: 34595914
[TBL] [Abstract] [Full Text] [Related]
17. Ultrasensitive, high-throughput and multiple cancer biomarkers simultaneous detection in serum based on graphene oxide quantum dots integrated microfluidic biosensing platform.
Wang C; Zhang Y; Tang W; Wang C; Han Y; Qiang L; Gao J; Liu H; Han L
Anal Chim Acta; 2021 Sep; 1178():338791. PubMed ID: 34482866
[TBL] [Abstract] [Full Text] [Related]
18. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract] [Full Text] [Related]
19. A strengthening the reporting of observational studies in epidemiology (STROBE): Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?
Dellino M; Gargano G; Tinelli R; Carriero C; Minoia C; Tetania S; Silvestris E; Loizzi V; Paradiso A; Casamassima P; Tufaro A; Cormio G; Garrisi VM
Medicine (Baltimore); 2021 Feb; 100(5):e24485. PubMed ID: 33592901
[TBL] [Abstract] [Full Text] [Related]
20. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics.
Cai G; Yang X; Ruan X; Wang J; Fang Y; Wei Y; Zhang Y; Gu M; Mueck AO
Maturitas; 2020 Oct; 140():64-71. PubMed ID: 32972637
[TBL] [Abstract] [Full Text] [Related]
[Next]
